Pharmaco - Press Releases

Date	Title	Company
21-Sep-2022	Xlife Sciences strengthens sustainability activities with ESG strategy	Xlife Sciences AG
20-Sep-2022	Merck Joins Accumulus Synergy as a Sponsor to Transform the Global Drug Regulatory Submission Process	Merck
20-Sep-2022	European Medicine Agency Accepts Marketing Authorization Applications for Bimekizumab in Psoriatic Arthritis and Axial Spondyloarthritis	UCB
20-Sep-2022	Otsuka announces EC approval of Lupkynis®▼ (voclosporin) as first oral treatment for active lupus nephritis	Otsuka
20-Sep-2022	Almirall: Tildrakizumab is the first and only IL-23p19 inhibitor to demonstrate meaningful sleep improvement in people living with psoriasis	Almirall
20-Sep-2022	APONTIS PHARMA announces cooperation to launch new Single Pill in Germany	APONTIS PHARMA AG
20-Sep-2022	Just – Evotec Biologics awarded contract from the U.S. Department of Defense under accelerated antibodies program	Evotec SE
19-Sep-2022	Epigenomics AG: Raise of earnings guidance for the current fiscal year 2022 due to currency gains and lower study costs	Epigenomics AG
19-Sep-2022	DEFENCE THERAPEUTICS APPLAUDS UNITED STATES PRESIDENT BIDEN CANCER MOONSHOT INITIATIVE	Defence Therapeutics Inc.
19-Sep-2022	Formycon publishes details of a previously undisclosed pipeline project – FYB206 is a biosimilar candidate for Keytruda®* (pembrolizumab)	Formycon AG
19-Sep-2022	Epigenomics Initiates prospective multi-center clinical trial for “Next-Generation” blood-based colorectal cancer test	Epigenomics AG
16-Sep-2022	Evotec initiates ground-breaking for new biologics facility J.POD® Toulouse, France (EU)	Evotec SE
16-Sep-2022	AEVIS VICTORIA SA – AEVS.SW – Half-year results 2022: Net profit jumps to CHF 47.2 million	AEVIS VICTORIA SA
15-Sep-2022	Abivax presents first-half 2022 financial results and operations update	ABIVAX
15-Sep-2022	Biophytis participates in H.C. Wainwright 24th Annual Global Investment Conference	Biophytis
15-Sep-2022	Kuros Biosciences announces successful CHF 6.0 million private placement	Kuros Biosciences AG
15-Sep-2022	Baader Bank initiates research coverage on Xlife Sciences	Xlife Sciences AG
15-Sep-2022	Relief Reports Half-Year 2022 Results and Provides Corporate Update	Relief Therapeutics Holding SA
15-Sep-2022	Newron provides H1 2022 results and updates on R&D and business activities	Newron Pharmaceuticals S.p.A.
14-Sep-2022	SOTIO Bolsters Leadership Team with Appointment of Martin Steegmaier as Chief Scientific Officer	B3C newswire